Last Price
32.00
Today's Change
-0.975 (2.95%)
Day's Change
31.74 - 33.47
Trading Volume
97,611
Profile
SYRE
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Cameron Turtle DPHIL, Ph.D. Dr. Cameron Turtle DPHIL, Ph.D.
Full Time Employees: 30 30
IPO Date: 2016-04-07 2016-04-07
CIK: 0001636282 0001636282
ISIN: US00773J2024 US00773J2024
CUSIP: 00773J202 00773J202
Beta: 2.91 2.91
Last Dividend: 0.00 0.00
Dcf Diff: 17.89 17.89
Dcf: 15.09 15.09
Description
Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
2
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
CEO Morning Brief
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
